October 4th 2025
Artificial intelligence, machine learning, and novel instruments are helping drug developers evaluate complex data from bioanalytical studies.
A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.